Formulation comprising antibacterial substance and antiulcer substance

Inactive Publication Date: 2001-10-04
AKIYAMA YOHKO +3
View PDF0 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

0007] The main object of the present invention is to provide a formulation for treating a

Problems solved by technology

However, there are some contractile cases in which no improvement occurs despite the appropriate treatment using these drugs, posing major problems.
Although some PPIs possessing anti-HP activity have been developed, they remain unsatisfactory as to healing effect when used alone because their antibacterial action against HP is not always sufficient.
Antibacterial substances such as amoxicillin (hereinafter also referred to as AMOX), metronidazole (hereinafter also referred to as MZ), bismuth subacetate and tetracycline, have been used against HP singly or in com

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Formulation comprising antibacterial substance and antiulcer substance
  • Formulation comprising antibacterial substance and antiulcer substance
  • Formulation comprising antibacterial substance and antiulcer substance

Examples

Experimental program
Comparison scheme
Effect test

reference example 2

[0146] Production of Gastrointestinal Mucosa-Adherent Solid Preparation Containing Compound A

[0147] 12 g of behenic acid hexa(tetra)glyceride (HB-310, trade name, produced by Sakamoto Yakuhin K.K.) was thermally molten at 85.degree. C., and 4 g of Compound A and 4 g of a poly (acrylic acid) (Hiviswako 104, Wako Pure Chemical Industries) were added, followed by stirring at 80.degree. C. for 15 minutes, to yield a dispersion. The resulting molten mixture was added drop by drop to an aluminum disk of 15 cm in diameter rotating at 1,500 rpm at 10 g / min to yield spherical fine subtilaes which pass through a 30-mesh sieve but not through an 80-mesh sieve (hereinafter referred to as 30 / 80 mesh).

reference example 3

[0148] Production of Gastrointestinal Mucosa-Adherent Solid Preparation Containing Amoxicillin (AMOX)

[0149] 75 g of behenic acid hexa(tetra)glyceride (HB-310, trade name, produced by Sakamoto Yakuhin K.K.) was thermally molten at 74.degree. C., and 10 g of AMOX and 15 g of a poly (acrylic acid) (Hiviswako 104, Wako Pure Chemical Industries) were added, followed by stirring at 74.degree. C. for 15 minutes, to yield a dispersion. The resulting molten mixture was added drop by drop to an aluminum disk of 15 cm in diameter rotating at 2,400 rpm at 10 g / min to yield 30 / 80 mesh spherical fine subtilaes.

[0150] For oral administration in humans or non-human animals, 100 mg of the above fine subtilaes was packed in No. 4 capsules to yield a capsular preparation.

reference example 4

[0151] Production of Gastrointestinal Mucosa-Adherent Solid Preparation Containing Compound A

[0152] 27.5 g of behenic acid hexa(tetra)glyceride (HB-310, trade name, produced by Sakamoto Yakuhin K.K.) was thermally molten at 85.degree. C., and 8 g of Compound A, 7.5 g of a poly (acrylic acid) (Hiviswako 104, Wako Pure Chemical Industries) and 10 g of tartaric acid were added, followed by stirring at 80.degree. C. for 15 minutes, to yield a dispersion. The resulting molten mixture was added drop by drop to an aluminum disk of 15 cm in diameter rotating at 2,400 rpm at 10 g / min to yield 30 / 80 mesh spherical fine subtilaes.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Dimensionless propertyaaaaaaaaaa
Dimensionless propertyaaaaaaaaaa
Massaaaaaaaaaa
Login to view more

Abstract

The present invention includes a formulation which comprises an antibacterial substance and an antiulcer substance, wherein at least either of them is formulated into a gastrointestinal mucosa-adherent solid preparation. The formulation of the present invention shows long retention time in the gastrointestinal tract because of adhesion to the gastrointestinal tract mucosa, synergetically enhances the pharmaceutical effects of an antibacterial substance, specially antibiotic against Helicobacter pylori (HP) and an antiulcer substance, with very low doses of active ingredients, particularly the anti-HP antibiotic with low prevalence of side effects. The present agent is useful as an antiulcer agent, showing potent anti-HP activity.

Description

[0001] The present invention relates to a formulation which comprises an antibacterial substance and an antiulcer substance, wherein at least either of them is formulated into a gastrointestinal mucosa-adherent solid preparation. The formulation of the present invention is used as an antiulcer agent and for other purposes.[0002] Since the isolation of Helicobacter pylori (hereinafter also referred to as HP) in 1983 [Lancet, 1, 1273 (1983)], its association with gastritis and digestive ulcer has drawn attention. This is because HP is found at high positivity rates in chronic gastritis or gastric ulcer [American Journal of Gastroenterology, 82, 2283 (1987)], despite the fact that it is normally not found in the mucosa of healthy humans [APMIS, 96, 84 (1988)].[0003] On the other hand, the development of H.sub.2 blockers and proton pump inhibitors (hereinafter also referred to as PPI) has resulted in markedly improved healing rates for gastric / duodenal ulcer. However, there are some con...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/16A61K9/32A61K9/50A61K9/58A61K31/43A61K31/44A61K45/06
CPCA61K9/1617A61K9/1635A61K9/5078A61K9/5084A61K31/43A61K31/44A61K45/06A61K2300/00A61K31/415A61K9/0065A61K31/4427A61K47/14
Inventor AKIYAMA, YOHKONAKAO, MASAFUMINAGAHARA, NAOKIIWASA, SUSUMU
Owner AKIYAMA YOHKO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap